2007 Keystone Symposium on Autophagy in Health and Disease

The first Keystone Symposium on Autophagy in Health and Disease was held in Monterey, a scenic city on the Pacific coast in central California, April 15-20, 2007. The symposium brought together approximately 280 participants, from basic researchers to physicians and journalists. The meeting was composed of a joint keynote session with the meeting "Apoptotic and Non-Apoptotic Cell Death Pathways" and eight plenary sessions, covering the molecular mechanisms of autophagy and many emerging concepts and functions of autophagy in organelle degradation, physiological regulation, cell death and survival, and disease. Three afternoon workshops focused on short talks selected from the posters, and a special discussion session led by experts dealt with techniques and concerns regarding experimental detection of autophagy. The symposium highlighted autophagy as a potential therapeutic target in a wide range of diseases, including cancer, microbial infection, myopathies and neurodegenerative disorders.     

4th International Symposium on Autophagy: exploiting the frontiers of autophagy research

The 4th International Symposium on Autophagy was held in Mishima, a small town between Tokyo and Kyoto, October 1-5, 2006 (http://isa4th.umin.jp/). The meeting was organized by the group of Eiki Kominami. Approximately 150 participants took part in this well-organized meeting in the spacious and comfortable Toray Conference Hall (Fig. 1). The social program offered opportunities for informal discussions, Japanese culture (from karaoke singing to traditional drumming; Fig. 2), history and nature (a visit to a steaming volcano; Fig. 3), as well as delicious Japanese food. The scientific program started with two plenary lectures on Sunday evening. Daniel Klionsky gave an overview of Atg9 cycling in yeast and Shigekazu Nagata talked about apoptosis and engulfment of dead cells by macrophages. The meeting consisted of five oral sessions and two poster sessions covering a wide range of autophagy-related topics. Exciting unpublished results were presented in all sessions, showing how quickly autophagy research is progressing. Two themes were discussed in many sessions during the symposium: the role of autophagy in the degradation of aggregate-prone proteins and protein aggregates, and the possible role of p62 in autophagy.     

Using phylogenies in conservation: new perspectives

The 2011 meeting of the European Ecological Federation took place in ávila, Spain, from 26th September to 29th September. The French Ecological Society (SFE) and the Foundation for Research on Biodiversity (FRB) sponsored a session entitled 'Evolutionary history, ecosystem function and conservation biology: new perspectives'. We report on the main insights obtained from this symposium.     

G6PD deficiency, diet, and adaptation to malaria

The symposium on “G6PD Deficiency, Diet, and Adaptation to Malaria” was held in Cortona, Italy on July 3,4,5 1995 under the auspices of the Congress of the International Union of Anthropological and Ethnological Sciences (IUAES). The Congress had actually taken place in Florence in April 1995, and the G6PD symposium was a satellite session to that meeting. Professor Brunetto Chiarelli, of the Istituto di Antropologia at the University of Florence, was the program chairman for the Congress. The general theme of the Congress was “Biodemography and Human Evolution,” and the G6PD symposium was consistent with this topic. In its broadest sense the symposium focused on biocultural factors which have influenced evolution at the G6PD locus and the pattern of population variation that has consequently emerged in this genetic system. A more specific sub-theme, reflected in the title of the symposium, was the interaction between dietary factors and the G6PD locus in providing antimalarial protection to human populations.     

Primary ciliary dyskinesia: a report from ATS 2001, May 18–23, San Francisco

Primary ciliary dyskinesia (PCD) is a genetic disorder of abnormal ciliary structure and function that leads to defective mucociliary clearance, resulting in oto-sino-pulmonary disease, and infertility. The disease is currently under intense investigation by a number of research groups worldwide. At the recent American Thoracic Society meeting in San Francisco in May 2001, two sessions focused on PCD; a symposium session on May 21 with several featured expert speakers was followed by a mini-symposium on Tuesday May 22, with one featured speaker and presentation of nine abstracts covering a range of research topics. Mattias Salathe (University of Miami, USA) and Stephen Brody (Washington University, St Louis, USA) chaired the symposium session. Presentations focused on the clinical spectrum of PCD, the genetics of PCD, a proteomics approach to detail the structure of cilia, the role of cilia in the embryology of situs laterality, and airway epithelial cell biology. The mini-symposium was chaired by Peadar Noone (University of North Carolina, USA) and Malcolm King (University of Alberta, USA) and included presentations on the use of PCD as a human disease model, accurate definition of the phenotype using clinical and cell biologic markers, and molecular studies. The latter reports ranged from isolation of a protein involved in ciliary structure and function to genetic studies using linkage analysis and the candidate gene approach. Clinicians and scientists alike displayed considerable interest at both sessions, and there were several lively question–answer sessions.     

2nd PEGS Annual Symposium on Antibodies for Cancer Therapy

The 2nd Annual Antibodies for Cancer Therapy symposium, organized again by Cambridge Healthtech Institute as part of the Protein Engineering Summit, was held in Boston, USA from April 30^th to May 1^st, 2012. Since the approval of the first cancer antibody therapeutic, rituximab, fifteen years ago, eleven have been approved for cancer therapy, although one, gemtuzumab ozogamicin, was withdrawn from the market. The first day of the symposium started with a historical review of early work for lymphomas and leukemias and the evolution from murine to human antibodies. The symposium discussed the current status and future perspectives of therapeutic antibodies in the biology of immunoglobulin, emerging research on biosimilars and biobetters, and engineering bispecific antibodies and antibody-drug conjugates. The tumor penetration session was focused on the understanding of antibody therapy using ex vivo tumor spheroids and the development of novel agents targeting epithelial junctions in solid tumors. The second day of the symposium discussed the development of new generation recombinant immunotoxins with low immunogenicity, construction of chimeric antigen receptors, and the proof-of-concept of ‘photoimmunotherapy’. The preclinical and clinical session presented antibodies targeting Notch signaling and chemokine receptors. Finally, the symposium discussed emerging technologies and platforms for therapeutic antibody discovery.     

AACR Annual Meeting 2008: autophagy in the forefront of cancer research

The 2008 American Association for Cancer Research (AACR) Annual Meeting was held in San Diego, CA, April 12-16, 2008 (http:// www.aacr.org/home/scientists/meetings--workshops/annual-meeting-2008.aspx). More than 17,000 scientists from 60 countries participated in this meeting that was organized by AACR, the oldest and largest organization in the world focused on cancer research. The scientific presentations included more than 6,000 abstracts and 500 invited talks on new and significant discoveries in basic, clinical, and translational cancer research. Autophagy, as pertaining to tumorigenesis and response to anticancer therapies, was undoubtedly a "hot topic" in this meeting. An educational session, a forum, a minisymposium and several other talks dispersed in different sessions had a strong focus on autophagy. All autophagy-related presentations were very well attended and stimulated lively discussions, clearly indicating that the scientific community is greatly interested in this rapidly-progressing area of research.     

2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30–May 1, 2012, Boston,USA

The 2nd Annual Antibodies for Cancer Therapy symposium, organized again by Cambridge Healthtech Institute as part of the Protein Engineering Summit, was held in Boston, USA from April 30^th to May 1^st, 2012. Since the approval of the first cancer antibody therapeutic, rituximab, fifteen years ago, eleven have been approved for cancer therapy, although one, gemtuzumab ozogamicin, was withdrawn from the market.  The first day of the symposium started with a historical review of early work for lymphomas and leukemias and the evolution from murine to human antibodies. The symposium discussed the current status and future perspectives of therapeutic antibodies in the biology of immunoglobulin, emerging research on biosimilars and biobetters, and engineering bispecific antibodies and antibody-drug conjugates. The tumor penetration session was focused on the understanding of antibody therapy using ex vivo tumor spheroids and the development of novel agents targeting epithelial junctions in solid tumors. The second day of the symposium discussed the development of new generation recombinant immunotoxins with low immunogenicity, construction of chimeric antigen receptors, and the proof-of-concept of ‘photoimmunotherapy’. The preclinical and clinical session presented antibodies targeting Notch signaling and chemokine receptors.  Finally, the symposium discussed emerging technologies and platforms for therapeutic antibody discovery.     

In praise of M. Anselmier who first used the term “autophagie” in 1859

A Google search for the combined terms “de Duve, autophagy, 1963” will reveal over 45,000 hits, most of them referring to the idea that the term autophagy was coined by the brilliant Christian de Duve on the sidelines of a symposium on lysosomes that took place in 1963. However, the first use of the term “autophagy” actually took place a century earlier.     

Use and commercialization of Podocnemis expansa (Schweiger 1812) (Testudines: Podocnemididae) for medicinal purposes in two communities in North of Brazil

The emergence of alternative medicines for AIDS in Asia and Africa was discussed at a satellite symposium and the parallel session on alternative and traditional treatments of the AIDSImpact meeting, held in Marseille, in July 2007. These medicines are heterogeneous, both in their presentation and in their geographic and cultural origin. The sessions focused on the role of these medications in selected resource poor settings in Africa and Asia now that access to anti-retroviral therapy is increasing. The aims of the sessions were to (1) identify the actors involved in the diffusion of these alternative medicines for HIV/AIDS, (2) explore uses and forms, and the way these medicines are given legitimacy, (3) reflect on underlying processes of globalisation and cultural differentiation, and (4) define priority questions for future research in this area. This article presents the insights generated at the meeting, illustrated with some findings from the case studies (Uganda, Senegal, Benin, Burkina Faso, China and Indonesia) that were presented. These case studies reveal the wide range of actors who are involved in the marketing and supply of alternative medicines. Regulatory mechanisms are weak. The efficacy claims of alternative medicines often reinforce a biomedical paradigm for HIV/AIDS, and fit with a healthy living ideology promoted by AIDS care programs and support groups. The AIDSImpact session concluded that more interdisciplinary research is needed on the experience of people living with HIV/AIDS with these alternative medicines, and on the ways in which these products interact (or not) with anti-retroviral therapy at pharmacological as well as psychosocial levels.     

Cancer Immunotherapy 2005: Mainz, Germany, 12–13 May 2005

Cancer Immunotherapy 2005 was the third international meeting organized by the Association for Immunotherapy of Cancer (AIC). About 200 participants were attracted by the excellent scientific program that consisted of overview lectures from 25 international speakers in the plenary auditorium and four guided poster sessions during both days of the meeting. The first day of the symposium mainly focused on experience with, and new perspectives in, antibody therapy. On the second day of the meeting, organized as a joint conference together with the Combined Research Grant “Mechanisms of Tumor Defense and Therapeutic Intervention” funded by the German Research Council, the participants had the chance to gain deeper insights into the principles of antigen processing and the regulation of immune responses. Further topics that were discussed mainly in the poster sessions and in the special lecture given by M. Nishimura (Chicago, USA), were “cellular therapies” and “vaccination against cancer”. The lectures selected for this report aim to provide an overview of the complete scientific program and give an impression of the lively atmosphere that could be felt from the first until the last session of CIMT 2005. C.M. Britten and C. Gouttefangeas contributed equally to this report.     

Biodiversity technologies: tools as change agents

A meeting on Biodiversity Technologies was held by the Biodiversity Institute, Oxford on the 27–28 of September 2012 at the Department of Zoology, University of Oxford. The symposium brought together 36 speakers from North America, Australia and across Europe, presenting the latest research on emerging technologies in biodiversity science and conservation. Here we present a perspective on the general trends emerging from the symposium.     

Barrels XXIII: Barrels by the shore

The 23rd annual Barrels meeting was held on the University of California, San Diego campus and highlighted the latest advances in the whisker-to-barrel pathway and beyond. The annual meeting brought together investigators from a dozen countries to present their data in posters and short talks. The meeting focused on several themes, first the barrel system was used as a model to study the consequences that result from alterations in the normal pattern(s) of development. A second session focused on what happens to whisker information once it leaves the layer IV barrel. A third session addressed issues of coding within the barrel system and a final session highlighted the latest advances in the engineering of transgenic mouse lines. The meeting highlighted the utility of the barrel system to study cortical circuitry in the normal and pathological state.     

Stem cells and their niche: an inseparable relationship

A recent Keystone symposium on 'Stem Cell Interactions with their Microenvironmental Niche' was organized by David T. Scadden and Allan C. Spradling. The meeting was held in conjunction with another Keystone symposium, 'Stem Cells and Cancer', at Keystone, Colorado. Among the work that was presented at this meeting, scientists presented data that advances our understanding of the contribution that the niche makes to stem cell maintenance. Novel types of stem cells and niches were also reported and new findings that clarify our understanding of the molecular mechanisms that regulate and maintain stem cells were presented.     

Past, present and future of ACE inhibitors

This satellite symposium was organised and sponsored by Servier. The aim of the symposium was to evaluate the past 30 years of experience with and the future of angiotensin-converting enzyme (ACE) inhibitors. The session was chaired by R. Ferrari (Ferrara, Italy) and M. Tendera (Katowice, Poland).     

Setting the standard in pulmonary hypertension management

This satellite symposium was organised and sponsored by Actelion. The symposium aimed to explore the importance of setting appropriate treatment goals for different patient populations with pulmonary arterial hypertension (PAH). The session was chaired by N. Galie (Bologna, Italy) and M. Humbert (Clamart, France).     

JIPB's Editorial Board Meeting 2009: A New Face in 2010

The annual editorial board meeting of JIPB, which this year coincided with the 2009 Integrative Plant Biology Symposium in the seaside town of Yantai, China, was recently concluded. Twenty-four editors attended the very constructive meeting (Figure 1). The symposium, partially sponsored by JIPB, at-tracted more than 300 participants from Chinese universities and research organizations.     

Social processes and disease in nonhuman primates: introduction to the special section

Most nonhuman primate species are remarkably social, but their social nature presents many challenges, including increased opportunities for pathogen transmission and development of disease (both physical and psychological). An interdisciplinary symposium was convened at the 2010 annual meeting of the American Society of Primatologists on the topic of social processes and disease in nonhuman primates, and four articles from that session, as well as a fifth that was separately solicited, appear in this special section. The articles reflect a variety of disciplines and perspectives that highlight the many ways that social processes can impact disease processes (and vice versa) in this highly social taxon. This is an increasingly active area of research interest as a consequence of technological developments and the availability of long-term field data. The continuing loss of primate habitat in the wild, climate change, and the need to manage high densities of primates in captivity, however, all add urgency to our need to better understand the bidirectional relationship between social factors and disease processes.     

From Bretonneau to therapeutic antibodies,from specificity to specific remedies,Saint-Cyr-Sur-Loire,France, November 19, 2012

Held on November 19, 2012 in Saint-Cyr-sur-Loire, France, the symposium “From Bretonneau to therapeutic antibodies, from specificity to specific remedies” focused on the historical development of antibodies as therapeutics, with an emphasis on the seminal work of the French physician Pierre-Fidèle Bretonneau (1778–1862). The morning session was devoted to discussion of the evolution of the concept of specificity in medicine, which started with an epistemological definition. The contributions of Bretonneau to the emergence of the concept of specificity, notably with his studies on diphtheria, and the subsequent development of antidiphtheric serotherapy in Europe during the period 1894–1898 were then presented in detail. The afternoon session began with a presentation on the role of French physiologists during the years 1860–1890 in establishing the basic concepts of specific immunity and the principles of serotherapy. The history of antivenom serotherapy, particularly its discovery by Césaire Phisalix, and the development of antilymphocyte globulins as successful transplantation drugs were then discussed. The symposium ended with the inauguration of a stele representing Bretonneau, who lived in Saint-Cyr-sur-Loire and died 150 y ago.     

Blurring the distinctions between insect pests of animals and plants

The Royal Entomological Society International Symposium on Insects and Disease was held at the University of Aberdeen on 10-12 September 2001. The symposium was run alongside the society's Annual Meeting (the first time this meeting has been held outside England) in association with the International Union of Forest Research Organisations and the Entomological Society of The Netherlands. The symposium was divided into three sessions: The Insect-Host-Disease Interface; Ecology, Epidemiology and Modelling, and Insect Control in the New Millennium.